Attached files
| file | filename |
|---|---|
| EX-4.9 - EXHIBIT 4.9 - AIkido Pharma Inc. | s102876_ex4-9.htm |
| EX-23.1 - EXHIBIT 23-1 - AIkido Pharma Inc. | s102876_ex23-1.htm |
| EX-31.1 - EXHIBIT 31-1 - AIkido Pharma Inc. | s102876_ex31-1.htm |
| EX-32.1 - EXHIBIT 32-1 - AIkido Pharma Inc. | s102876_ex32-1.htm |
| EX-31.2 - EXHIBIT 31-2 - AIkido Pharma Inc. | s102876_ex31-2.htm |
| EX-21.1 - EXHIBIT 21.1 - AIkido Pharma Inc. | s102876_ex21-1.htm |
| EX-10.23 - EXHIBIT 10-23 - AIkido Pharma Inc. | s102876_ex10-23.htm |
| EX-10.24 - EXHIBIT 10-24 - AIkido Pharma Inc. | s102876_ex10-24.htm |
| EX-10.26 - EXHIBIT 10-26 - AIkido Pharma Inc. | s102876_ex10-26.htm |
| 10-K - FORM 10-K - AIkido Pharma Inc. | s102876_10k.htm |
Exhibit 32.2
Certification of
Chief Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Frank Reiner, Interim Chief Financial Officer of Spherix Incorporated (the “Company”), in compliance with Section 906 of the Sarbanes-Oxley Act of 2002, hereby certify that, to the best of my knowledge, the Company’s Annual Report on Form 10-K for the period ended December 31, 2015 (the “Report”) filed with the Securities and Exchange Commission:
| Fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
/s/ Frank Reiner | |
| Frank Reiner | |
| Interim Chief Financial Officer | |
| (Principal Financial Officer and Principal Accounting Officer) | |
| March 29, 2016 |
A signed copy of this written statement required by Section 906 has been provided to Spherix Incorporated and will be retained by Spherix Incorporated and furnished to the Securities and Exchange Commission or its staff upon request.